Our Products
Three products in development, each combining our Quantum Technologies and AI/ML divisions into practical, deployable healthcare solutions.
An integrated healthcare product for continuous patient monitoring, combining biosensing, physiological monitoring, data processing, risk visualization, and early-warning capabilities within a unified system. Its design focuses on creating a practical, user-friendly healthcare solution that supports continuous monitoring and timely identification of potential cardiac risk.

An integrated healthcare product for continuous infant respiratory monitoring, combining SpO₂, ECG, lung-sound, and biochemical sensing with on-device processing and wireless connectivity for real-time risk monitoring. Its design focuses on a compact, portable, and offline-capable healthcare solution that can provide early alerts to caregivers, particularly in rural and resource-limited environments.

Integrates advanced fetal ultrasound imaging with AI-driven analysis for real-time cardiac assessment. Hybrid NISQ quantum computing enhances complex pattern recognition and analysis of subtle fetal heart abnormalities. The system enables early detection of congenital heart defects (CHDs) such as VSD, ASD, TOF, and coarctation. Quantum-enhanced risk prediction provides early anomaly assessment and probability-based cardiac risk insights — delivering secure, non-invasive, and clinically supportive prenatal screening for faster and more accurate decision-making.
